Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Adverse Event Mitigation in Gene Therapy for nAMD
Szilard Kiss, MD
Carl D. Regillo, MD, FACS, FASRS
How Gene Therapy Is Designed to Work in Retinal Disease
Lejla Vajzovic, MD, FASRS
Beyond Anti-VEGF: The Emerging Durability Landscape
Gene Therapy for nAMD: Focus on Future Readiness
Gene Therapy for nAMD: Navigating the Next Era of Durable Retinal Treatment
Rethinking Dry Eye Disease: Evolving Strategies for Evaluation and Care
Steve Jackson, PharmD
Esen K. Akpek, MD
Patient-Centered Care in Dry Eye Disease
Kaleb Abbott, OD, FAAO
EMPOWER - Ocular Surface Disease: Latest Innovations In Dry Eye And Meibomian Gland Dysfunction
Jacob Lang
Josh Davidson, OD, FSLS, FAAO
Mark Dunbar
Retinas at Risk: Real-World Cases in High Disease Activity and Adherence Challenges
Interpreting Gene Therapy Data With Confidence
Uncovering the Drivers of Dry Eye Symptoms
Anat Galor, MD, MSPH
Seeing the Signs of Dry Eye Disease
John D. Sheppard, MD
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Optimizing Anti-VEGF Selection in Diabetic Macular Edema
Michael A. Klufas, MD
Diagnostic Vitrectomy for Infectious Uveitis
Steven Yeh, MD, FASRS
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.